Following the Israeli Health Ministry’s recommendation of omega-3 fatty acids and phytosterols for cardiovascular health, dietary supplement marketer Ta’am Teva Altman has launched No-Sterol, a supplement formulated by Soft Gel Technologies.
Following the Israeli Health Ministry’s May 2011 recommendation of omega-3 fatty acids and phytosterols for cardiovascular health, dietary supplement marketer Ta’am Teva Altman has launched No-Sterol, a supplement formulated by Soft Gel Technologies Inc. (Los Angeles, CA).
No-Sterol is designed for cholesterol maintenance and overall heart health. The formula contains phytosterols, omega-3 fatty acids, and coenzyme Q10 (CoQ10).
“We are very proud to be collaborating with Ta’am Teva Altman on this product,” said Soft Gel export director Roy Bouskila. “Many consumers currently seek options for controlling cholesterol through natural measures, and this formula has had some very encouraging results.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.